Business programme

Fighting Infections: Future Risks

04 Jun , 12:00–13:15
Joining Forces to Advance Development
Congress Centre, conference hall D4

The COVID-19 pandemic has not only necessitated the rapid development of effective and safe vaccines against the coronavirus, it has also launched a trend of creating next-generation vaccines, with the prospect of using vaccine platforms in other areas of medicine. This has brought the issue of infectious diseases back to the forefront. Having seen the SARS-CoV-2 virus at work and its disastrous effect on human health, scientists are now predicting and preparing for future infectious catastrophes. The unprecedented challenge to the global community caused by the pandemic clearly demonstrates the importance of vaccination as the most effective method of preventing future catastrophes. New infections are a major threat to humankind, and we must learn to counter them. The last year has seen a globally consolidated scientific search for effective infection prevention tools capable of averting the negative effect of infections on socioeconomic life and human health. Can modern science predict the specifics of future infections, thereby enabling it to quickly react to new challenges? How well do COVID-19 vaccines protect the public from the coronavirus, and how effective will they be in the future? How soon will the global population be vaccinated, and what international cooperation solutions can be used to accelerate this process? Is it possible to keep the coronavirus under control in perpetuity? How effective is the new Strategy for the Development of Immunoprophylaxis in Russia at addressing the aims of improving government policy in this sector, stimulating scientific development and clinical research, and increasing Russian public trust in and awareness of the positive effects of vaccination?

Sergey Brilev, Anchor; President, The Global Energy Association

Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (online)
Kirill Dmitriev, Chief Executive Officer, Russian Direct Investment Fund (RDIF)
Mikhail Murashko, Minister of Health of the Russian Federation
Anna Popova, Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing - Chief State Sanitary Physician of the Russian Federation
Nenad Popovic, Minister for Innovation and Technological Development, Government of the Republic of Serbia
Alexey Repik, Chairman, Delovaya Rossiya (Business Russia); Chairman of the Board, Group R-Pharm
Robert Steffen, Professor, Department of Epidemiology and Prevention of Infectious Diseases, University of Zurich
Yuli Edelstein, Minister of Health of the State of Israel (online)

Front row participants
Deborah Waterhouse, Chief Executive Officer, ViiV Healthcare, member of Corporate Executive Team, GSK (online)
Aleksandr Gintsburg, Director, "National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation (online)